PURPOSE: This study describes the development of surfactant-free, biodegradable nanoparticle systems with varying physicochemical properties and their suitability for pulmonary application via nebulization. METHODS: Nanoparticle suspensions were formulated from the branched polyester, diethylaminopropyl amine-poly(vinyl alcohol)-grafted-poly(lactide-co-glycolide) (DEAPA-PVAL-g-PLGA) alone, as well as with increasing amounts of carboxymethyl cellulose (CMC). Particle size, zeta potential, turbidity, and morphology (atomic force microscopy) were characterized. Three formulations were chosen for further study: Cationic nanoparticles without CMC, cationic nanoparticles with CMC, and anionic nanoparticles with an excess of CMC. Nanoparticle degradation was characterized, as well as stability during nebulization. Nanoparticle-cell interactions were investigated and quantified using confocal laser scanning microscopy and fluorescence spectrometry. RESULTS: Nanoparticles ranged in size from 70-250 nm and displayed zeta potentials of +58.9 to -46.6 mV. Anionic nanoparticles showed the highest stability during nebulization. The degradation rate of each nanoparticle formulation decreased with increasing amounts of CMC. Cell association was highest among cationic nanoparticles (57% and 30%, respectively), although these were not internalized. Despite a lower rate of cell association (3%), anionic nanoparticles were internalized by A549 cells. CONCLUSIONS: Surfactant-free nanoparticles from DEAPA-PVAL-g-PLGA are versatile drug delivery systems; however, only the anionic formulations investigated were proven suitable for aerosol therapy.
PURPOSE: This study describes the development of surfactant-free, biodegradable nanoparticle systems with varying physicochemical properties and their suitability for pulmonary application via nebulization. METHODS: Nanoparticle suspensions were formulated from the branched polyester, diethylaminopropyl amine-poly(vinyl alcohol)-grafted-poly(lactide-co-glycolide) (DEAPA-PVAL-g-PLGA) alone, as well as with increasing amounts of carboxymethyl cellulose (CMC). Particle size, zeta potential, turbidity, and morphology (atomic force microscopy) were characterized. Three formulations were chosen for further study: Cationic nanoparticles without CMC, cationic nanoparticles with CMC, and anionic nanoparticles with an excess of CMC. Nanoparticle degradation was characterized, as well as stability during nebulization. Nanoparticle-cell interactions were investigated and quantified using confocal laser scanning microscopy and fluorescence spectrometry. RESULTS: Nanoparticles ranged in size from 70-250 nm and displayed zeta potentials of +58.9 to -46.6 mV. Anionic nanoparticles showed the highest stability during nebulization. The degradation rate of each nanoparticle formulation decreased with increasing amounts of CMC. Cell association was highest among cationic nanoparticles (57% and 30%, respectively), although these were not internalized. Despite a lower rate of cell association (3%), anionic nanoparticles were internalized by A549 cells. CONCLUSIONS: Surfactant-free nanoparticles from DEAPA-PVAL-g-PLGA are versatile drug delivery systems; however, only the anionic formulations investigated were proven suitable for aerosol therapy.
Authors: Lea Ann Dailey; Thomas Schmehl; Tobias Gessler; Matthias Wittmar; Friedrich Grimminger; Werner Seeger; Thomas Kissel Journal: J Control Release Date: 2003-01-09 Impact factor: 9.776
Authors: J K Miller; R Neubig; C B Clemons; K L Kreider; J P Wilber; G W Young; A J Ditto; Y H Yun; A Milsted; H T Badawy; M J Panzner; W J Youngs; C L Cannon Journal: Ann Biomed Eng Date: 2012-08-10 Impact factor: 3.934
Authors: Young H Lim; Kristin M Tiemann; David A Hunstad; Mahmoud Elsabahy; Karen L Wooley Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2016-03-25
Authors: A E Stine; D Nassar; J K Miller; C B Clemons; J P Wilber; G W Young; Y H Yun; C L Cannon; J G Leid; W J Youngs; A Milsted Journal: Math Biosci Date: 2013-04-27 Impact factor: 2.144
Authors: Claudia B Packhaeuser; Kerstin Lahnstein; Johannes Sitterberg; Thomas Schmehl; Tobias Gessler; Udo Bakowsky; Werner Seeger; Thomas Kissel Journal: Pharm Res Date: 2008-10-08 Impact factor: 4.200
Authors: Melissa Skibba; Adam Drelich; Michael Poellmann; Seungpyo Hong; Allan R Brasier Journal: Front Pharmacol Date: 2020-12-11 Impact factor: 5.810